The use of a probiotic Lactobacillus rhamnosus and a probiotic
Bifidobacterium longumin the manufacture of a medicament or therapeutic
nutritional composition for administration to an infant during at least
the first three months of life for the long-term prophylaxis of diarrhoea
in infants and young children.